A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Clinical trial NCT04615325 · COMPLETED
Trial details
- NCT number
- NCT04615325
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-08
- Primary completion
- 2023-01-04
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.